• Thu, February 20, 2025

by: WOPRAI

Short squeeze is starting in shares of ESCA at $15.97, after crossing above the $15.941 Trigger Price

by: Bloomberg

Meta Platforms' record winning streak puts stock split in view

The move can also spur bullish sentiment. The average return for stocks one year after a split tops 25 per cent, against 12 per cent for the broader market, according to BofA's analysis. The showing was even stronger in 2024, with the average stock up 17 per cent in the subsequent six months.

by: MoneyWeek

How to invest in frontier markets

Frontier markets can be extremely risky, but they offer access to exotic stocks in rapidly developing countries

by: Kiplinger

Stock Market Today: Growth Concerns Drag on Stocks

Forward-looking commentary from a major retailer outweighed its backward-looking results as all three major equity indexes retreated on Thursday.

by: Which

Price of gold hits record high - should you invest?

The price of gold has risen by 44% in the past year, peaking at a record $2,942 per troy ounce last week. Investors are flocking to the classic 'safe haven' of gold in response to political and economic turbulence,

by: MSN

Vanguard vs. Fidelity: Which Broker Offers the Best Value?

When it comes to investing, Vanguard vs. Fidelity are two of the biggest names. We'll break down fees, investment strategies, features to help you pick one.

by: Moneyweb

Big money left the JSE 10 years ago

JREwing commented: "All the big money has left the JSE 10 years ago and invested in the Dow Jones, Nasdaq, S&P and they made an absolute killing, 100% - 500% returns and more. These were the real smart people, the patriots of the JSE were left with some crumbs or debt before Sars wants its cut also."

by: CNN

Dow falls 450 points as inflation and tariff fears hit Main Street

US stocks fell Thursday after the world's largest retailer warned that 2025 would be a rollercoaster ride and said it expected sales to slow this year amid fears that consumers are tapped out.

by: MSN

Why I'm All In on Aritzia and BlackBerry Stock for the Next 10 Years

Here's why Canadian growth stocks like Aritzia and BlackBerry have the potential to multiply your hard-earned savings in the long run. The post Why I'm All In on Aritzia and BlackBerry Stock for the Next 10 Years appeared first on The Motley Fool Canada.

by: WOPRAI

Short squeeze is starting in shares of HIW at $29.44, after crossing above the $29.404 Trigger Price

by: CNN

Dow falls 600 points as inflation and tariff fears hit Main Street

US stocks fell Thursday after the world's largest retailer warned that 2025 would be a rollercoaster ride and said it expected sales to slow this year amid fears that consumers are tapped out. The sour forecast from Walmart (WMT) dragged down the Dow by ...

by: Kiplinger

Why Alibaba Stock Is Soaring After Earnings

Alibaba stock is higher Thursday after the China-based e-commerce platform beat expectations for its fourth quarter. Here's what you need to know.

by: Kiplinger

Palantir Stock: Why One Analyst Says to Buy the Dip

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here's what you need to know.

by: MSN

Billionaire Blackrock CEO Larry Fink Says People Are Saving Too Much And Not Investing Enough To 'Retire With Dignity'

Imagine spending decades working hard, setting aside money, and expecting a comfortable retirement—only to realize too late that saving alone wasn't enough. According to billionaire BlackRock CEO Larry Fink,

by: WOPRAI

Short squeeze is starting in shares of UWMC at $6.685, after crossing above the $6.67 Trigger Price

by: MSN

J.P. Morgan vs. Vanguard: Which Is the Best Personal Advisor for You?

If you need a personal advisor, should you choose J.P. Morgan vs. Vanguard? Here's all you need to know about each to help figure out which is best for you.

by: WOPRAI

Short squeeze is starting in shares of HUIZ at $3.45, after crossing above the $3.434 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of HAS at $69.145, after crossing above the $68.702 Trigger Price

by: MSN

Here's Why You Should Consider Investing in Cintas Stock Now

Cintas Corporation CTAS is well-poised to benefit from strength across its business, acquisitions, focus on improving the product line and operational excellence. The company remains focused on investing in growth opportunities and solidifying its long-term market position.

by: WOPRAI

Short squeeze is starting in shares of CMRE at $10.5, after crossing above the $10.498 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ULTA at $363.66, after crossing above the $363.262 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TWI at $9.235, after crossing above the $9.211 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TD at $60.165, after crossing above the $60.138 Trigger Price

  • Fri, February 21, 2025

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of TrueBlue, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Mativ Holdings, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Luminar Media Group, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of NeuroSense Therapeutics Ltd. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of The Alkaline Water Company Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Pinstripes Holdings Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of NerdWallet, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Vivic Corp. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Aptose Biosciences Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Webstar Technology Group, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Mullen Automotive, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of ProPhase Labs, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Nexalin Technology, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Yotta Acquisition Corporation in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of TMC the metals company Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Ceres Power Holdings plc in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Editas Medicine, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Vivos Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Jet.AI Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of CEL-SCI Corporation in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Foremost Lithium Resource & Technology Ltd. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of JRSIS Health Care Corporation in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of Iveda Solutions, Inc. in recent trading

by: WOPRAI

As of Feb 21st, 2025, there has been substantial selling of in recent trading

by: WOPRAI

42 Earnings Releases for Feb 21st, 2025

Palantir Stock: Why One Analyst Says to Buy the Dip

Palantir stock is continuing to slide Thursday as investors weigh a CEO stock sale and potential defense budget cuts. Here's what you need to know.
The article from Kiplinger discusses the investment perspective on Palantir Technologies (PLTR) stock, highlighting why one analyst recommends buying the dip. Analyst Mariana Perez Mora from BofA Global Research has upgraded Palantir's stock from Neutral to Buy, setting a price target of $28, which suggests a potential 25% increase from its current price. This optimistic outlook is based on Palantir's strong performance in its commercial business, particularly in the U.S., where it has shown significant growth. Despite a dip in stock price following its Q4 earnings, the analyst points out that Palantir's focus on AI and machine learning, along with its expanding customer base, positions it well for future growth. The article also notes that while the stock has been volatile, the company's strategic direction and market positioning make it an attractive buy for investors looking at long-term gains.

Read the Full Kiplinger Article at:
https://www.kiplinger.com/investing/stocks/palantir-pltr-stock-why-one-analyst-says-to-buy-the-dip